Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia

Sangeeta Desai, So Dug Lim, Rafael E Jimenez, Thomas Chun, Thomas E. Keane, Jesse K. Mckenney, Angel Zavala-Pompa, Cynthia Cohen, Robert H. Young, Mahul B. Amin

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

The aim of this study was to assess the relationship of immunoreactivity of cytokeratin 20 (CK20) and CD44 across the spectrum of urothelial neoplasia using the WHO/ISUP consensus classification. A total of 120 papillary urothelial pTa and pT1 tumors (8 papillomas, 8 neoplasms of low malignant potential, and 42 low-grade and 62 high-grade carcinomas) were immunostained by using CK20 and CD44 antibodies. The relationships of tumor grade, pathologic stage, recurrences, and progression in stage with CK20 and CD44 immunoreactivity were assessed. WHO/ISUP grade correlated with tumor stage (P < 0.005), recurrence (P = 0.02), and progression in stage (P = 0.031). Normal urothelium showed CK20 immunoreactivity restricted to a few umbrella cells. Expression of CD44 in normal urothelium was restricted to the basal cell layer. Loss of CD44 immunoreactivity and increasing CK20 positivity were significantly associated with increasing tumor grade and stage (P < 0.005). An inverse relationship was observed in the staining patterns of CK20 and CD44 within individual cases, as well as in the aggregate data, with 79.2% of tumors with CD44 loss showing CK20 positivity (P < 0.001). In conclusion, CK20 and CD44 immunoreactivity are significantly related to the WHO/ISUP grade and to each other, and our data suggest their potential combined utility in predicting biologic behavior in patients with papillary urothelial pTa and pT1 neoplasms.

Original languageEnglish (US)
Pages (from-to)1315-1323
Number of pages9
JournalModern Pathology
Volume13
Issue number12
DOIs
StatePublished - 2000
Externally publishedYes

Fingerprint

Keratin-20
Neoplasms
Proteins
Urothelium
Recurrence
Papilloma
Staining and Labeling
Carcinoma
Antibodies

Keywords

  • CD44
  • CK20
  • Papillary neoplasia
  • Pathologic stage
  • Prognosis
  • Transitional cell carcinoma
  • Urinary bladder
  • WHO/ISUP classification

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. / Desai, Sangeeta; Dug Lim, So; Jimenez, Rafael E; Chun, Thomas; Keane, Thomas E.; Mckenney, Jesse K.; Zavala-Pompa, Angel; Cohen, Cynthia; Young, Robert H.; Amin, Mahul B.

In: Modern Pathology, Vol. 13, No. 12, 2000, p. 1315-1323.

Research output: Contribution to journalArticle

Desai, S, Dug Lim, S, Jimenez, RE, Chun, T, Keane, TE, Mckenney, JK, Zavala-Pompa, A, Cohen, C, Young, RH & Amin, MB 2000, 'Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia', Modern Pathology, vol. 13, no. 12, pp. 1315-1323. https://doi.org/10.1038/modpathol.3880241
Desai, Sangeeta ; Dug Lim, So ; Jimenez, Rafael E ; Chun, Thomas ; Keane, Thomas E. ; Mckenney, Jesse K. ; Zavala-Pompa, Angel ; Cohen, Cynthia ; Young, Robert H. ; Amin, Mahul B. / Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. In: Modern Pathology. 2000 ; Vol. 13, No. 12. pp. 1315-1323.
@article{04c517d5b91b4cd3aeb8a29f86ecaa4a,
title = "Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia",
abstract = "The aim of this study was to assess the relationship of immunoreactivity of cytokeratin 20 (CK20) and CD44 across the spectrum of urothelial neoplasia using the WHO/ISUP consensus classification. A total of 120 papillary urothelial pTa and pT1 tumors (8 papillomas, 8 neoplasms of low malignant potential, and 42 low-grade and 62 high-grade carcinomas) were immunostained by using CK20 and CD44 antibodies. The relationships of tumor grade, pathologic stage, recurrences, and progression in stage with CK20 and CD44 immunoreactivity were assessed. WHO/ISUP grade correlated with tumor stage (P < 0.005), recurrence (P = 0.02), and progression in stage (P = 0.031). Normal urothelium showed CK20 immunoreactivity restricted to a few umbrella cells. Expression of CD44 in normal urothelium was restricted to the basal cell layer. Loss of CD44 immunoreactivity and increasing CK20 positivity were significantly associated with increasing tumor grade and stage (P < 0.005). An inverse relationship was observed in the staining patterns of CK20 and CD44 within individual cases, as well as in the aggregate data, with 79.2{\%} of tumors with CD44 loss showing CK20 positivity (P < 0.001). In conclusion, CK20 and CD44 immunoreactivity are significantly related to the WHO/ISUP grade and to each other, and our data suggest their potential combined utility in predicting biologic behavior in patients with papillary urothelial pTa and pT1 neoplasms.",
keywords = "CD44, CK20, Papillary neoplasia, Pathologic stage, Prognosis, Transitional cell carcinoma, Urinary bladder, WHO/ISUP classification",
author = "Sangeeta Desai and {Dug Lim}, So and Jimenez, {Rafael E} and Thomas Chun and Keane, {Thomas E.} and Mckenney, {Jesse K.} and Angel Zavala-Pompa and Cynthia Cohen and Young, {Robert H.} and Amin, {Mahul B.}",
year = "2000",
doi = "10.1038/modpathol.3880241",
language = "English (US)",
volume = "13",
pages = "1315--1323",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia

AU - Desai, Sangeeta

AU - Dug Lim, So

AU - Jimenez, Rafael E

AU - Chun, Thomas

AU - Keane, Thomas E.

AU - Mckenney, Jesse K.

AU - Zavala-Pompa, Angel

AU - Cohen, Cynthia

AU - Young, Robert H.

AU - Amin, Mahul B.

PY - 2000

Y1 - 2000

N2 - The aim of this study was to assess the relationship of immunoreactivity of cytokeratin 20 (CK20) and CD44 across the spectrum of urothelial neoplasia using the WHO/ISUP consensus classification. A total of 120 papillary urothelial pTa and pT1 tumors (8 papillomas, 8 neoplasms of low malignant potential, and 42 low-grade and 62 high-grade carcinomas) were immunostained by using CK20 and CD44 antibodies. The relationships of tumor grade, pathologic stage, recurrences, and progression in stage with CK20 and CD44 immunoreactivity were assessed. WHO/ISUP grade correlated with tumor stage (P < 0.005), recurrence (P = 0.02), and progression in stage (P = 0.031). Normal urothelium showed CK20 immunoreactivity restricted to a few umbrella cells. Expression of CD44 in normal urothelium was restricted to the basal cell layer. Loss of CD44 immunoreactivity and increasing CK20 positivity were significantly associated with increasing tumor grade and stage (P < 0.005). An inverse relationship was observed in the staining patterns of CK20 and CD44 within individual cases, as well as in the aggregate data, with 79.2% of tumors with CD44 loss showing CK20 positivity (P < 0.001). In conclusion, CK20 and CD44 immunoreactivity are significantly related to the WHO/ISUP grade and to each other, and our data suggest their potential combined utility in predicting biologic behavior in patients with papillary urothelial pTa and pT1 neoplasms.

AB - The aim of this study was to assess the relationship of immunoreactivity of cytokeratin 20 (CK20) and CD44 across the spectrum of urothelial neoplasia using the WHO/ISUP consensus classification. A total of 120 papillary urothelial pTa and pT1 tumors (8 papillomas, 8 neoplasms of low malignant potential, and 42 low-grade and 62 high-grade carcinomas) were immunostained by using CK20 and CD44 antibodies. The relationships of tumor grade, pathologic stage, recurrences, and progression in stage with CK20 and CD44 immunoreactivity were assessed. WHO/ISUP grade correlated with tumor stage (P < 0.005), recurrence (P = 0.02), and progression in stage (P = 0.031). Normal urothelium showed CK20 immunoreactivity restricted to a few umbrella cells. Expression of CD44 in normal urothelium was restricted to the basal cell layer. Loss of CD44 immunoreactivity and increasing CK20 positivity were significantly associated with increasing tumor grade and stage (P < 0.005). An inverse relationship was observed in the staining patterns of CK20 and CD44 within individual cases, as well as in the aggregate data, with 79.2% of tumors with CD44 loss showing CK20 positivity (P < 0.001). In conclusion, CK20 and CD44 immunoreactivity are significantly related to the WHO/ISUP grade and to each other, and our data suggest their potential combined utility in predicting biologic behavior in patients with papillary urothelial pTa and pT1 neoplasms.

KW - CD44

KW - CK20

KW - Papillary neoplasia

KW - Pathologic stage

KW - Prognosis

KW - Transitional cell carcinoma

KW - Urinary bladder

KW - WHO/ISUP classification

UR - http://www.scopus.com/inward/record.url?scp=17744364702&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17744364702&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3880241

DO - 10.1038/modpathol.3880241

M3 - Article

C2 - 11144928

AN - SCOPUS:17744364702

VL - 13

SP - 1315

EP - 1323

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 12

ER -